Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Doxorubicin

Known as: Hydroxyldaunorubicin, 5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)-, Doxorubicin [Chemical/Ingredient] 
An anthracycline antibiotic with antineoplastic activity. Doxorubicin, isolated from the bacterium Streptomyces peucetius var. caesius, is the… Expand
National Institutes of Health

Related topics

Related topics

48 relations
AC-T RegimenCDE protocol-cyclophosphamide/doxorubicin/etoposideCHVmP-VB protocolCOPP-ABV Regimen
Expand

Narrower (20)

ACP protocolCHOP protocol-cyclophosphamide/doxorubicin/prednisone/vincristineCISCA protocolDOXO-cell
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
DNA Nanotechnology-Enabled Drug Delivery Systems.
Over the past decade, we have seen rapid advances in applying nanotechnology in biomedical areas including bioimaging… Expand
Is this relevant?
Review
2018
Review
2018
Molecular mechanism of doxorubicin‐induced cardiomyopathy – An update
Abstract Doxorubicin is utilized for anti‐neoplastic treatment for several decades. The utility of this drug is limited due to… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Review
2018
Review
2018
Toxicity of Doxorubicin (Dox) to different experimental organ systems
&NA; Doxorubicin (Dox) is a valuable anticancer drug for hematologic and solid tumors. Yet, it can cause multi‐organ toxicities… Expand
  • table 1
Is this relevant?
Review
2018
Review
2018
Recent Advances in the Application of Vitamin E TPGS for Drug Delivery
D-ɑ-tocopheryl polyethylene glycol succinate (Vitamin E TPGS or TPGS) has been approved by FDA as a safe adjuvant and widely used… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Review
2018
Review
2018
Current Challenges of Cancer Anti-angiogenic Therapy and the Promise of Nanotherapeutics
With growing interest in cancer therapeutics, anti-angiogenic therapy has received considerable attention and is widely… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Review
2017
Review
2017
Supramolecular chemotherapy based on host-guest molecular recognition: a novel strategy in the battle against cancer with a bright future.
Chemotherapy is currently one of the most effective ways to treat cancer. However, traditional chemotherapy faces several… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2017
Review
2017
Cancer nanomedicine: a review of recent success in drug delivery
Cancer continues to be one of the most difficult global healthcare problems. Although there is a large library of drugs that can… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 5
Is this relevant?
Review
2017
Review
2017
Endoplasmic reticulum stress signaling and chemotherapy resistance in solid cancers
The unfolded protein response (UPR) is an adaptive cellular program used by eukaryotic cells to cope with protein misfolding… Expand
  • figure 1
  • table 3
  • figure 2
  • figure 3
Is this relevant?
Review
2017
Review
2017
Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium
Despite scientific and clinical advances in the field of pharmacogenomics (PGx), application into routine care remains limited… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2016
Review
2016
New insights and evolving role of pegylated liposomal doxorubicin in cancer therapy.
We herein review various pharmacological and clinical aspects of pegylated liposomal doxorubicin (PLD), the first nanomedicine to… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE